Cathy Maes

719 total citations
13 papers, 441 citations indexed

About

Cathy Maes is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Cathy Maes has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Infectious Diseases and 3 papers in Immunology. Recurrent topics in Cathy Maes's work include Respiratory viral infections research (5 papers), Pneumonia and Respiratory Infections (5 papers) and Influenza Virus Research Studies (4 papers). Cathy Maes is often cited by papers focused on Respiratory viral infections research (5 papers), Pneumonia and Respiratory Infections (5 papers) and Influenza Virus Research Studies (4 papers). Cathy Maes collaborates with scholars based in Belgium, United States and United Kingdom. Cathy Maes's co-authors include Geert Leroux‐Roels, Fien De Boever, François Roman, Emmanuel Hanon, Isabel Leroux‐Roels, Mamadou Dramé, Frédéric Clément, Paul Gillard, Julie Willekens and Marcelle Van Mechelen and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Cathy Maes

12 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Maes Belgium 10 326 128 108 71 45 13 441
Fien De Boever Belgium 10 361 1.1× 185 1.4× 179 1.7× 74 1.0× 74 1.6× 17 491
Taff Jones Canada 11 260 0.8× 152 1.2× 155 1.4× 19 0.3× 60 1.3× 20 396
Mohinder Sidhu United States 13 583 1.8× 83 0.6× 159 1.5× 36 0.5× 57 1.3× 16 654
Mirian Fernández-Alonso Spain 13 297 0.9× 76 0.6× 118 1.1× 16 0.2× 60 1.3× 26 416
Jesse Bodle Australia 7 180 0.6× 119 0.9× 86 0.8× 19 0.3× 46 1.0× 10 346
Pei Xu United States 13 323 1.0× 37 0.3× 159 1.5× 14 0.2× 44 1.0× 16 367
Helen May‐Lin Oh Singapore 9 308 0.9× 74 0.6× 233 2.2× 64 0.9× 41 0.9× 12 408
Joanne Hiebert Canada 13 364 1.1× 69 0.5× 168 1.6× 84 1.2× 30 0.7× 39 468
Subhash V. Kapre India 13 309 0.9× 37 0.3× 146 1.4× 27 0.4× 67 1.5× 24 429
Gabriel Defang United States 12 192 0.6× 66 0.5× 127 1.2× 75 1.1× 96 2.1× 19 403

Countries citing papers authored by Cathy Maes

Since Specialization
Citations

This map shows the geographic impact of Cathy Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Maes more than expected).

Fields of papers citing papers by Cathy Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Maes. The network helps show where Cathy Maes may publish in the future.

Co-authorship network of co-authors of Cathy Maes

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Maes. A scholar is included among the top collaborators of Cathy Maes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Maes. Cathy Maes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Leroux‐Roels, Isabel, Jacques Bruhwyler, Lilli Stergiou, et al.. (2023). Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine. Vaccines. 11(2). 367–367. 9 indexed citations
2.
Leroux‐Roels, Isabel, Cathy Maes, Bart Jacobs, et al.. (2022). A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine. Frontiers in Immunology. 13. 1021500–1021500. 17 indexed citations
3.
Tregoning, John S., January Weiner, Deniz Cizmeci, et al.. (2020). Pregnancy has a minimal impact on the acute transcriptional signature to vaccination. npj Vaccines. 5(1). 29–29. 8 indexed citations
4.
5.
Leroux‐Roels, Geert, Cathy Maes, Annelies Aerssens, et al.. (2019). Safety and Immunogenicity of a Second Dose of an Investigational Maternal Trivalent Group B Streptococcus Vaccine in Nonpregnant Women 4–6 Years After a First Dose: Results From a Phase 2 Trial. Clinical Infectious Diseases. 70(12). 2570–2579. 22 indexed citations
6.
7.
Leroux‐Roels, Geert, Cathy Maes, Julie Willekens, et al.. (2016). A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. Vaccine. 34(15). 1786–1791. 50 indexed citations
8.
Leroux‐Roels, Geert, Cathy Maes, Fien De Boever, et al.. (2014). Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study. Vaccine. 32(50). 6838–6846. 55 indexed citations
9.
Leroux‐Roels, Geert, Cathy Maes, Frédéric Clément, et al.. (2013). Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS ONE. 8(2). e55438–e55438. 59 indexed citations
10.
Leroux‐Roels, Geert, Edwige Haelterman, Cathy Maes, et al.. (2011). Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine. Clinical and Vaccine Immunology. 18(9). 1510–1518. 18 indexed citations
11.
Roman, François, Frédéric Clément, Walthère Dewé, et al.. (2011). Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials. Clinical and Vaccine Immunology. 18(5). 835–843. 44 indexed citations
12.
13.
Maes, Cathy, et al.. (2004). IMMUNE REACTIVITY OF MYCOBACTERIUM BOVIS (STRAIN BCG) AND MYCOBACTERIUM VACCAE. 3(12). 7–18. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fien De Boever Breakdown of academic impact, for papers by Taff Jones Breakdown of academic impact, for papers by Mohinder Sidhu Breakdown of academic impact, for papers by Mirian Fernández-Alonso Breakdown of academic impact, for papers by Jesse Bodle Breakdown of academic impact, for papers by Pei Xu Breakdown of academic impact, for papers by Helen May‐Lin Oh Breakdown of academic impact, for papers by Joanne Hiebert Breakdown of academic impact, for papers by Subhash V. Kapre Breakdown of academic impact, for papers by Gabriel Defang
Rankless by CCL
2026